Sign Up Today and Learn More About Flare Therapeutics Stock
Invest in or calculate the value of your shares in Flare Therapeutics or other pre-IPO companies through EquityZen's platform.
Flare Therapeutics Stock (FLTH)
Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.
About Flare Therapeutics Stock
Founded
2021
Headquarters
Cambridge, MA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Flare Therapeutics Press Mentions
Stay in the know about the latest news on Flare Therapeutics
Flare Therapeutics’ Post
linkedin • Aug 03, 2024
Flare Therapeutics Presents Data at AACR 2024 Annual Meeting Characterizing PPARG-Derived Immune Cell ...
prnewswire • May 23, 2024
Flare Therapeutics on LinkedIn: #bladdercancerawarenessmonth #liftthetorch #transcriptionfactors #biotech
linkedin • May 23, 2024
Flare Therapeutics Names New CEO
contractpharma • May 05, 2024
Flare Therapeutics appoints Douglas Manion as CEO
thepharmaletter • Apr 24, 2024
Flare Therapeutics Management
Leadership team at Flare Therapeutics
Board Member
Abbie Celniker
Board Member
Craig Gordon
Join now and verify your accreditation status to gain access to:
- Flare Therapeutics current valuation
- Flare Therapeutics stock price
- Available deals in Flare Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Flare Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Flare Therapeutics through EquityZen funds. These investments are made available by existing Flare Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Flare Therapeutics stock?
Shareholders can sell their Flare Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
